Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 5, 1997, Pages 997-1010

  Daftari, Inder K ^a,b,c,e   Char, Devron H ^a   Verhey, Lynn J ^a,c   Castro, Joseph R ^a,b,c   Petti, Paula L ^a,b   Meecham, William J ^a,d   Kroll, Stewart ^a   Blakely, Eleanor A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Kaiser Permanent ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eye; Helium ion therapy; Neovascular glaucoma; Treatment planning; Uveal melanoma

Indexed keywords

ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; FEMALE; HELIUM ION RADIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME; UVEA MELANOMA; UVEA TUMOR;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTERIOR EYE SEGMENT; EYE ENUCLEATION; FEMALE; GLAUCOMA, NEOVASCULAR; HELIUM; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROBABILITY; UVEAL NEOPLASMS;

EID: 0030667809     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00557-9     Document Type: Article

References (49)

1. Adamis, A. P.; Miller, J. W.; Bernal, M. T.; D'Amico, D. J.; Folkman, J.; Yeo, T. K.; Yeo, K. T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:445-450; 1994.
2. Aiello, L. P.; Avery, R. L.; Arrigg, P. G.; Keyt, B. A.; Jampel, H. D.; Shah, S. T.; Thieme, H.; Iwamoto, M. A.; Park, J. E.; Nguyen, H. V.; Ajello, L. M.; Ferrara, N.; King, G. L. Vascular cndothclial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487; 1994.
3. Aiello, L. P.; Pierce, E. A.; Foley, E. D.; Takagi, H.; Chen, H.; Riddle, L.; Ferrara, N.; King, G. L.; Smith, L. E. H. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92:10457-10461; 1995.
4. Anderson, P. K.; Borgan, O.; Gill, R. D.; Keiding, N. Statistical models based on counting processes. New York: Springer Verlag; 1993
5. Augsburger, J. J.; Magargal, L. E.; Roth, S. E.; Shields, J. A. Panretinal photocoagulation for radiation-induced ocular ischemia. Ophthal. Surg. 18:589-593; 1987.
6. Bedford, M. A.; Bedotto, C.; McFaul, P. A. Radiation retinopathy after application of a cobalt plaque. Br. J. Ophthalmol. 54:505-509; 1970.
7. Blakely, E. A.; Bjornstad, K. A.; Daftari, I. K.; Renner, T. R.; Nyman. M. A.; Singh, R. P.; Flocchini, R.; Netherton, J.; Verhey, L. J.; Castro, J. R.; Char, D. H. 68 MeV proton radiobiology for treatment of uveal melanoma. 44th annual meeting of Radiation Research society. Chicago, IL.: 1996:76.
8. Blakely, E. A.; Daftari, I. K.; Meecham, W. J.; Alonso, L. C.; Collier, J. M.; Kroll, S. M.; Gillette, E. L.; Lee, A. C.; Lett, J. T.; Cox, A. B.; Castro, J. R.; Char, D. H. Helium-ion-induced human cataractogenesis. Adv. Space Res. 14:501-505; 1994.
9. Cappin, J. M. Malignant of glaucoma in eyes with uveal malignant melanomas. Int. Ophthal. Clin. 12:51-62; 1972.
10. Castro, J. R.; Char, D. H.; Petti, P. L.; Daftari, I. K.; Quivey, J. M.; Singh, R. P.; Blakely, E. A.; Phillips, T. L. 15 years experience with helium ion radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 36:200; 1996.
11. Chapman, J. D.; Blakely, E. A.; Smith, A. B.; Urtasun, R. C. Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. Int. J. Radiat. Oncol. Biol. Phys. 3:97-102; 1977.
12. Char, D. H. Clinical ocular oncology 2nd. ed. Philadelphia: Lippincott-Raven; 1997
13. Char, D. H.; Castro, J. R. Helium ion therapy for choroidal melanoma. Arch. Ophthalmol. 100:935-938; 1982.
14. Char, D. H.; Castro, J. R.; Kroll, S. M.; Irvine, A. R.; Quivey, J. M.; Stone, R. D. Five-year follow-up of helium ion therapy for uveal melanoma. Arch. Ophthalmol. 108:209-214; 1990.
15. Char, D. H.; Castro, J. R.; Quivey, J. M.; Chen, G. T. Y.; Lyman, J. T.; Stone, R. D.; Irvine, A. R.; Barricks, M.; Crawford, J. B.; Hilton, G. F.; Lonn, L. I.; Schwartz A. Helium ion charged particle therapy for choroidal melanoma. Ophthalmology. 87:565-570; 1980.
16. Char, D. H.; Lonn, L. E.; Margolis, L. W. Complications of cobalt plaque therapy of choroidal melanomas. Am. J. Ophthalmol. 84:536-541; 1977.
17. Char, D. H.; Quivey, J. M.; Castro; J. R.; Kroll, S.; Phillips, T. L. Helium ions versus Iodine-125 brachytherapy in the management of uveal melanoma, a prospective, randomized, dynamically balanced trial. Ophthalmology 100:1547-1554; 1993.
18. Char, D. H.; Stone, R. D.; Irvine, A. R.; Crawford, J. B.; Hilton, G. F.; Lonn, L. I.; Schwartz, A. Diagnostic modalities in choroidal melanoma. Am. J. of Ophthalmol. 89:223-230; 1980.
19. Cox, D. R. Regression models and life-tables (with discussion). J. R. Stat. Soc. 634:187-220; 1972.
20. Crawford, J. B.; Char, D. H. Histopathology of uveal melanomas treated with charged particle radiation. Arch. Ophthalmol. 94:639-643; 1987.
21. Daftari, I. K.; Renner, T. R.; Verhey, L. J.; Singh, R. P.; Nyman, M.; Petti, P. L.; Castro, J. R. New UCSF proton ocular beam facility at the Crocker Nuclear Laboratory cyclotron (UC Davis). Nucl. Instrum. Methods Phys. Res. A380: 597-612; 1996.
22. Decker, M.; Castro, J. R.; Linstadt, D. E.; Char, D.; Petti, P. L.; Quivey, J. M.; Ahn, D. Ciliary body melanoma treated with helium particle irradiation. Int. J. Radiat. Oncol. Biol. Phys. 19:243-247; 1990.
23. Finger, P. T.; Moshfeghi, D. M.; Ho, T. K. Palladium 103 ophthalmic plaque radiotherapy. Arch Ophthalmol. 109:1610-1613; 1991.
24. Garretson, B. R.; Robertson, D. M.; Earle, J. K. Choroidal melanoma treatment with iodine-125 brachytherapy. Arch Ophthalmol. 105:1394-1397; 1987.
25. Goitein, M.; Miller, T. Planning proton therapy of the eye. Med. Phys. 10:275-283; 1983.
26. Gragoudas, E. S.; Goitein, M.; Koehler, A. M.; Verhey, L; Tepper, J.; Suit, H.; Brockhurst, R.; Constable, I. J. Proton irradiation of small choroidal malignant melanomas. Am. J. Ophthalmol. 83:665-673; 1977.
27. Gragoudas, E. S.; Goitein, M.; Verhey, L.; Munzenreider, J.; Suit, H. D.; Koehler, A. Proton beam irradiation: An alternative to enucleation for intraocular melanomas. Ophthalmology 87:571-581; 1980.
28. Gragoudas, E. S.; Seddon, J.; Egan, K.; Goitein, M.; Munzenrider, J.; Verhey, L.; Austin-Seymour, M.; Urie, M.; Koehler, A. Present results of proton beam irradiation of uveal melanoma. In XXVth Intern. Cong. of Opthal. Rome: Kugler & Ghedini, 1986:911-916.
29. Gragoudas, E. S.; Seddon, J. M.; Egan, K.; Glynn, R.; Munzenrider, J.; Austin-Seymour, M.; Goitein, M.; Verhey, L.; Urie, M.; Koehler, A. Long term results of proton beam irradiated uveal melanomas. Ophthalmology 94:349-353; 1987.
30. Kalbfleisch, J. D.; Prentice, R. L. The statistical analysis of failure time data. New York, Wiley; 1980
31. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
32. Kim, M. K.; Char, D. H.; Castro, J. R.; Saunders, W. M.; Chen, G. T. Y.; Stone, R. D. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology 93:189-193; 1986.
33. Leith, J. T.; Ainsworth, E. A.; Alpen, E. L. Heavy-ion radiobiology: Normal tissue studies. Adv. Radiat. Biol. 10:191-236; 1983.
34. Leung, D. W.; Cachianes, G.; Kuang, W.-J.; Goeddel, D. V.; Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309; 1989.
35. Linstadt, D.; Castro, J.; Char, D.; Decker, M.; Ahn, D.; Petti, P.; Nowkowski, V.; Quivey, J.; Phillips, T. L. Long-term results of helium ion irradiation of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 19:613-618; 1990.
36. Linstadt, D.; Char, D. H.; Castro, J. R.; Phillips, T. L.; Quivey, J. M.; Reimers, M.; Hannigan, J.; Collier, J. M. Vision following helium ion radiotherapy of uveal melanoma: A Northern California Oncology Group Study. Int. J. Radiat. Oncol. Biol. Phys. 15:347-352; 1988.
37. Lommatzch, P. Treatment of choroidal melanoma with 106-Rh beta-ray applicators. Surv. Ophthalmol. 19:85; 1974.
38. Lyman, J. T.; Chong, C. Y. ISAH: A versatile treatment positioner for external radiation therapy. Cancer 34:12-16; 1974.
39. Meecham, W. J.; Char, D. H.; Kroll, S.; Castro, J. R.; Blakely, E. A. Anterior segment complications after helium ion irradiation therapy for uveal melanoma. Radiation cataract. Arch. Ophthalmol. 112:197-203; 1994.
40. Moura, R. A.; McPherson, A. R.; Easley, J. Malignant melanoma of the choroid: Treatment with episcleral 198-Au plaque and xenon-arc photocoagulation. Ophthalmology 17:114-125; 1985.
41. Munzenrider, J. E.; Gragoudas, E. S.; Seddon, J. M.; Sisterson, J.; McNulty, P.; Birnbaum, S.; Johnson, K.; Austin-Seymour, M.; Slater, J.; Goitein, M. M.; Verhey, L. J.; Urie, M.; Ruotolo, D. M.; Egan, K.; Osuna, F. Conservative treatment of uveal melanoma: Probability of eye retention after proton treatment. Int. J. Radiat. Oncol. Biol. Phys. 15:553-558; 1988.
42. Rodriguez, A.; Levy, R. P.; Fabrikant, J. I. Experimental central nervous system injury after charged-particle irradiation. In: Gutin, P. H., Leibel, S. A., Sheline, G. E., ed. Radiation injury to the nervous system. New York: Raven Press Ltd.; 1991.
43. Saunders, W. M.; Char, D. H.; Quivey, J. M.; Castro. J. R.; Chen, G. T. Y.; Collier, J. M.; Cartigny, A.; Blakely, E. A.; Lyman, J. T.; Zink, S. R.; Tobias, C. A. Precision, high dose radiotherapy: Helium ion treatment of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 11:227-233; 1985.
44. Seddon, J. M.; Gragoudas, E. S.; Albert, D. M.; Polivogianis, L.; Hsieh, C. C.; Friedenberg, G. R. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am. J. Ophthalmol. 99:282-290; 1985.
45. Seddon, J. M.; Gragoudas, E. S.; Polivogianis, L.; Hsieh, C. C.; Egan, K. M.; Goitein, M.; Verhey, L.; Munzenrider, J.; Austin-Seymour, M.; Urie, M.; Koehler, A. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 93:666-674; 1986.
46. Sheen, M. A. Development of the EYE proton therapy planning program. XX PTCOG Meeting. Chester, England (May 16-18):, 1994:29.
47. Shields, J. A.; Augsburge, J. J.; Brady, L. W.; Day, J. L. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology 89:1201-1207; 1982.
48. Thieme, H.; Aiello, L. P.; Takagi, H.; Ferrara, N.; King, G. L. Comparative analysis of Vascular Endothelial Growth Factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44:98-103; 1995.
49. Urano, M.; Verhey, L. J.; Goitein, M.; Tepper, J. E.; Suit, H. D.; Mendiondo, O.; Gragoudas, E. S.; Koehler, A. Relative biological effectiveness of modulated proton beams in various murine tissues. Int. J. Radiat. Oncol. Biol. Phys. 10:509-514; 1984.